Aquaporin-4 Knockout Abolishes Apomorphine-Induced Tardive Dyskinesia Following Chronic Treatment with Neuroleptics

CNS Neuroscience and Therapeutics

Volumn 18, Issue 12, 2012, Pages 1024-1026

  Su, Cun Jin ^a   Xu, Xiao Qing ^a   Fan, Yi ^a   Du, Ren Hong ^a   Hu, Gang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; AQUAPORIN 4; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT;

ASTROCYTE; CELL PROLIFERATION; CORPUS STRIATUM; DRUG INDUCED DISEASE; GLIA CELL; HUMAN; INVOLUNTARY MOVEMENT; LETTER; LOCOMOTION; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RISK REDUCTION; TARDIVE DYSKINESIA;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; AQUAPORIN 4; CLOZAPINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HALOPERIDOL; HIPPOCAMPUS; MALE; MASTICATION; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MOVEMENT DISORDERS;

EID: 84870446598     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12020     Document Type: Letter

References (10)

1. Baldessarini RJ, Gardner DM. Incidence of extrapyramidal syndromes and tardive dyskinesia. J Clin Psychopharmacol 2011;31:382-384.
2. Pena MS, Yaltho TC, Jankovic J. Tardive dyskinesia and other movement disorders secondary to aripiprazole. Mov Disord 2011;26:147-152.
3. Nord M, Farde L. Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci Ther 2011;17:97-103.
4. Perreault ML, O'Dowd BF, George SR. Dopamine receptor homooligomers and heterooligomers in schizophrenia. CNS Neurosci Ther 2011;17:52-57.
5. Turrone P, Remington G, Nobrega JN. The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy. Neurosci Biobehav Rev 2002;26:361-380.
6. Zeng XN, Xie LL, Liang R, Sun XL, Fan Y, Hu G. AQP4 knockout aggravates ischemia/reperfusion injury in mice. CNS Neurosci Ther 2012;18:388-394.
7. Chi Y, Fan Y, He L, et al. Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease. Aging Cell 2011;10:368-382.
8. Liu L, Lu Y, Kong H, et al. Aquaporin-4 deficiency exacerbates brain oxidative damage and memory deficits induced by long-term ovarian hormone deprivation and D-galactose injection. Int J Neuropsychopharmacol 2012;15:55-68.
9. Weis S, Llenos IC. GFAP-immunopositive astrocytes in schizophrenia. Schizophr Res 2004;67:293-295.
10. Arif M, Chikuma T, Ahmed MM, Yoshida S, Kato T. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions. Neurosci Res 2007;57:248-258.